ORIGINAL RESEARCH article
Front. Oncol., 03 April 2019
Sec. Pharmacology of Anti-Cancer Drugs
Volume 9 - 2019 | https://doi.org/10.3389/fonc.2019.00188
RETRACTED: Oroxylin a Inhibits the Protection of Bone Marrow Microenvironment on CML Cells Through CXCL12/CXCR4/P-gp Signaling Pathway
- HC
Hanbo Cao 1
- WL
Wenjun Li 1
- YZ
Yizhou Zhou 1
- RT
Renxiang Tan 2
- YY
Yue Yang 1
- YZ
You Zhou 1
- QG
Qinglong Guo 1*
- LZ
Li Zhao 1*
1. State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, Nanjing, China
2. State Key Laboratory Cultivation Base for TCM Quality and Efficacy, Nanjing University of Chinese Medicine, Nanjing, China
Summary
Citation
Cao H, Li W, Zhou Y, Tan R, Yang Y, Zhou Y, Guo Q and Zhao L (2019) RETRACTED: Oroxylin a Inhibits the Protection of Bone Marrow Microenvironment on CML Cells Through CXCL12/CXCR4/P-gp Signaling Pathway. Front. Oncol. 9:188. doi: 10.3389/fonc.2019.00188
Received
19 January 2019
Accepted
05 March 2019
Published
03 April 2019
Volume
9 - 2019
Edited by
Carmen Alvarez-Lorenzo, University of Santiago de Compostela, Spain
Reviewed by
Agnieszka Zdzisława Robaszkiewicz, University of Łódź, Poland; Amarjit Luniwal, North American Science Associates Inc., United States
Updates
This article was submitted to Pharmacology of Anti-Cancer Drugs, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.